Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-05-04
Haugen Janet Brutschea Files West Pharmaceutical Services (WST) Form 4 - May 04, 2026
Haugen Janet Brutschea bought 791 WST shares in this Form 4 filing, reported to the SEC on 2026-05-04.
- Insider
- Haugen Janet Brutschea
- Issuer
- West Pharmaceutical Services Inc. WST · NYSE
- Filed
- Period
- 2026-05-04
- Accession
- 0000105770-26-000060
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Haugen Janet Brutschea | 2026-05-04 | Buy | 791 | $0.00 | $0.00 | Direct |
| Net change | +791 | $0.00 | ||||
About West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.
Track WST insider activity
Get alerted when West Pharmaceutical Services Inc. executives buy or sell their shares.